# Epigenetic, Genetic, and Functional Germline Alterations of PAX Genes in Human Pathology: A Comprehensive Update

**Authors:** Valentina Lopez Gomez, Samantha Wegner, Stephanie Ocejo, Dezaray Perez, Diana Jabbour, Virginia Fernandez, Amr Abulaban, Marwan Bahmad, Tarec K. Elajami, Wassim Abou-Kheir, Hisham F. Bahmad

PMC · DOI: 10.3390/cimb48020236 · 2026-02-23

## TL;DR

This paper reviews how mutations in PAX genes lead to various human diseases, emphasizing their role in development and disease mechanisms.

## Contribution

The paper offers a comprehensive overview of germline PAX gene mutations and their clinical implications across multiple organ systems.

## Key findings

- Germline mutations in PAX genes are linked to a range of congenital disorders with variable expressivity and overlapping symptoms.
- PAX proteins play roles in postnatal tissue maintenance and immune function, expanding their clinical relevance beyond embryonic development.
- The paper integrates molecular genetics with human pathology to clarify genotype–phenotype correlations and disease classification.

## Abstract

Paired box (PAX) genes encode a family of nine transcription factors that function as master regulators of embryogenesis, organogenesis, and lineage specification. Their tightly regulated spatial and temporal expression is essential for the development of multiple organ systems, including the central nervous system, eyes, kidneys, immune system, musculoskeletal system, and endocrine organs. Germline mutations of PAX genes result in a broad and often pleiotropic spectrum of human disease, reflecting the developmental programs governed by each family member. Pathogenic variants in PAX genes underlie diverse congenital disorders such as aniridia (PAX6), renal coloboma syndrome (PAX2), otofaciocervical syndrome with immunodeficiency (PAX1), Waardenburg syndrome (PAX3), maturity-onset diabetes of the young (PAX4), and tooth agenesis (PAX9). These conditions frequently demonstrate variable expressivity, incomplete penetrance, and overlapping phenotypes, which make it challenging to be clinically recognized. Beyond embryogenesis and embryologic development, emerging evidence indicates that several PAX proteins remain active in postnatal tissue maintenance, adult stem cell regulation, immune function, and regenerative responses (particularly PAX7 in skeletal muscle satellite cells and PAX5 in B-cell homeostasis), further expanding their clinical relevance. This review provides a synopsis of the major, clinically relevant, germline PAX gene mutations, emphasizing genotype–phenotype correlations, developmental mechanisms, and disease classification across the organ systems. By integrating molecular genetics with human pathology, we highlight the diagnostic implications of PAX genes as central determinants of congenital disease and provide a framework for understanding how alterations in the developmental transcriptional networks translate into human pathology.

## Linked entities

- **Genes:** PAX6 (paired box 6) [NCBI Gene 5080], PAX2 (paired box 2) [NCBI Gene 5076], PAX1 (paired box 1) [NCBI Gene 5075], PAX3 (paired box 3) [NCBI Gene 5077], PAX4 (paired box 4) [NCBI Gene 5078], PAX9 (paired box 9) [NCBI Gene 5083], PAX7 (paired box 7) [NCBI Gene 5081], PAX5 (paired box 5) [NCBI Gene 5079]
- **Diseases:** aniridia (MONDO:0019172), renal coloboma syndrome (MONDO:0007352), Waardenburg syndrome (MONDO:0018094), maturity-onset diabetes of the young (MONDO:0018911), tooth agenesis (MONDO:0005486)

## Full-text entities

- **Genes:** PAX7 (paired box 7) [NCBI Gene 5081] {aka CMYO19, CMYP19, HUP1, MYOSCO, PAX7B, RMS2}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, FOXO1 (forkhead box O1) [NCBI Gene 2308] {aka FKH1, FKHR, FOXO1A}, SNAI2 (snail family transcriptional repressor 2) [NCBI Gene 6591] {aka SLUG, SLUGH, SLUGH1, SNAIL2, WS2D}, NKX2-8 (NK2 homeobox 8) [NCBI Gene 26257] {aka NKX2.8, NKX2H, Nkx2-9}, PAX5 (paired box 5) [NCBI Gene 5079] {aka ALL3, BSAP, PAX-5}, EDNRB (endothelin receptor type B) [NCBI Gene 1910] {aka ABCDS, ET-B, ET-BR, ETB, ETB1, ETBR}, PAX8 (paired box 8) [NCBI Gene 7849] {aka PAX-8}, NKX2-1 (NK2 homeobox 1) [NCBI Gene 7080] {aka BCH, BHC, NK-2, NKX2.1, NKX2A, NMTC1}, DNMT1 (DNA methyltransferase 1) [NCBI Gene 1786] {aka ADCADN, AIM, CXXC9, DNMT, HSN1E, MCMT}, MIR142 (microRNA 142) [NCBI Gene 406934] {aka MIRN142, mir-142}, WWTR1 (WW domain containing transcription regulator 1) [NCBI Gene 25937] {aka TAZ}, PAX3 (paired box 3) [NCBI Gene 5077] {aka CDHS, HUP2, PAX-3, WS1, WS3}, CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, EDN3 (endothelin 3) [NCBI Gene 1908] {aka ET-3, ET3, HSCR4, PPET3, WS4B}, GCG (glucagon) [NCBI Gene 2641] {aka GLP-1, GLP1, GLP2, GRPP}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, NCOA1 (nuclear receptor coactivator 1) [NCBI Gene 8648] {aka F-SRC-1, KAT13A, RIP160, SRC1, bHLHe42, bHLHe74}, WT1 (WT1 transcription factor) [NCBI Gene 7490] {aka AWT1, GUD, NPHS4, WAGR, WIT-2, WT-1}, MZF1 (myeloid zinc finger 1) [NCBI Gene 7593] {aka MZF-1, MZF1B, ZFP98, ZNF42, ZSCAN6}, ZEB1 (zinc finger E-box binding homeobox 1) [NCBI Gene 6935] {aka AREB6, BZP, DELTAEF1, FECD6, NIL2A, PPCD3}, MITF (melanocyte inducing transcription factor) [NCBI Gene 4286] {aka CMM8, COMMAD, MI, MITF-A, WS2, WS2A}, NCOA2 (nuclear receptor coactivator 2) [NCBI Gene 10499] {aka GRIP1, KAT13C, NCoA-2, SRC-2, SRC2, TIF2}, TG (thyroglobulin) [NCBI Gene 7038] {aka AITD3, TGN}, GADD45G (growth arrest and DNA damage inducible gamma) [NCBI Gene 10912] {aka CR6, DDIT2, GADD45gamma, GRP17}, PAX1 (paired box 1) [NCBI Gene 5075] {aka HUP48, OFC2, OTFCS2}, SOX10 (SRY-box transcription factor 10) [NCBI Gene 6663] {aka DOM, PCWH, SOX-10, WS2E, WS4, WS4C}, PAX2 (paired box 2) [NCBI Gene 5076] {aka FSGS7, PAPRS, PAX-2}, MSX1 (msh homeobox 1) [NCBI Gene 4487] {aka ECTD3, HOX7, HYD1, STHAG1}, PAX4 (paired box 4) [NCBI Gene 5078] {aka KPD, MODY9}, TPO (thyroid peroxidase) [NCBI Gene 7173] {aka MSA, TDH2A, TPX}, PAX9 (paired box 9) [NCBI Gene 5083] {aka STHAG3}, MAML3 (mastermind like transcriptional coactivator 3) [NCBI Gene 55534] {aka CAGH3, ERDA3, GDN, MAM-2, MAM2, TNRC3}, PAX6 (paired box 6) [NCBI Gene 5080] {aka AN, AN1, AN2, ASGD5, D11S812E, FVH1}
- **Diseases:** ptosis (MESH:C564553), maturity-onset diabetes of the young type 9 (MESH:C567393), Wilms tumor-aniridia (MESH:D009396), sinonasal sarcoma (MESH:C535701), early-onset diabetes (MESH:C536739), craniofacial anomalies (MESH:D019465), inherited predisposition syndrome (MESH:D020022), acute lymphoblastic leukemia (MESH:D054198), autosomal recessive syndrome of failure to thrive (MESH:D005183), OTFCS2 (MESH:C563481), Jarcho-Levin syndrome (MESH:C535781), CKD (MESH:D012080), congenital hypothyroidism (MESH:D003409), CAKUT (MESH:C566906), colorectal and pancreatic cancers (MESH:D015179), leukemia (MESH:D007938), WS type 2 (MESH:C536463), vesicoureteral reflux (MESH:D014718), neonatal hypothyroidism (MESH:D007037), immunodeficiency (MESH:D007153), congenital myopathy (MESH:D009224), endometrial and renal neoplasms (MESH:D016889), keratopathy (MESH:C562399), metastasis (MESH:D009362), KFS (MESH:D007714), AH (MESH:D007039), MYOSCO (MESH:D012600), alveolar rhabdomyosarcoma (MESH:D018232), absence of posterior teeth (MESH:C563203), axial hypotonia (MESH:D009123), polydactyly (MESH:D017689), rib anomalies (MESH:C537613), invasive (MESH:D009361), glioblastoma (MESH:D005909), neurodevelopmental impairment (MESH:D009422), Ph (MESH:D010677), thyroid hypoplasia or ectopy (MESH:C566852), renal cell carcinoma (MESH:D002292), brain malformations (MESH:D020785), developmental delay (MESH:D002658), PAX2-related disorder (MESH:D019973), extrathyroid malformations (MESH:C564254), spectrum (MESH:C579922), hypodontia (MESH:D000848), ocular disease (MESH:D005128), glucose intolerance (MESH:D018149), hepatocellular carcinoma (MESH:D006528), insulin-dependent diabetes (MESH:D003922), agenesis of the pineal gland (MESH:D010871), ovarian and renal cancer (MESH:D010051), axial and cardiac malformations (MESH:D006331), parathyroid adenomas (MESH:D010282), rhabdomyoblastic differentiation (MESH:D012734), glaucoma (MESH:D005901), myopathy (MESH:D009135), vertebral and shoulder-girdle anomalies (MESH:D020968), lymph-node metastasis (MESH:D008207), isolated renal disease (MESH:D007674), WS4 (OMIM:277580), genitourinary anomalies-intellectual disability (MESH:D014564)
- **Chemicals:** BioRender (-), steroid (MESH:D013256), 5-aza-2'-deoxycytidine (MESH:D000077209)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** c.76A>G, IVS7-1G>A, c.113G>A, Val27fs, p.Arg240*, c.61C>T, c.1013-2A>G, c.626C>A, c.1A>C, P80R, 718C>T, p.Val265fs, c.117_128del12, p.Gly183Ser, L44V, c.106G>C, p.Tyr386*, proline/serine, p.Gly41Val, p.Arg104*, c.112del, p.Gly128fs, R121W, c.1104C>A, p.Ser369Arg, Cys70   Tyr, p.Glu93Alafs30, p.Pro25Arg, p.Arg49His, c.565G>A, c.575G>A, p.Val263Gly, p.Cys368*, c.139C>T, c.1212dup, c.619_624dup, c.72_76dup, L1, c.1173_1174insGCCCG, p.Arg140Ile, c.239C>G, c.278_281del, c.209G>A, c.76delG, p.Arg108*, c.667C>T, P20L, CCC (Pro) to CTC (Leu), p.Arg38Glyfs16, G deletion of nucleotide 935, p.Gly51Ser, c.122G>T, p.Trp100*, c.139A>G, p.Gly36Arg, p.Arg38Ter, p.Lys114Ter, c.555dupA, p.Arg203*, c.788T>G

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939336/full.md

---
Source: https://tomesphere.com/paper/PMC12939336